A Day Up For XTL Biopharmaceuticals Ltd.
Wed, Apr 29, 2026 at 07:37 PM
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ) shot up at $3.56, representing a gain of 54.1%. On Wed, Apr 29, 2026, XTLB:NASDAQ hit a New 2-Week High of $3.56. The stock got featured on our News Catalysts scanner on Wed, Apr 29, 2026 at 12:17 PM in the 'BIOTECH' category. From Wed, Apr 15, 2026, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Apr 29, 2026 at $4.87 with a volume of 113M+.
About XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ)
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Top 10 Gainers:
- Rising Dragon Acquisition Corp. (RDAC:NASDAQ), 318.57%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 84.67%
- Borealis Foods Inc. (BRLS:NASDAQ), 67.26%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 54.11%
- Inno Holdings Inc. (INHD:NASDAQ), 50%
- Akanda Corp. (AKAN:NASDAQ), 48.6%
- Silicon Motion Technology Corporation (SIMO:NASDAQ), 45.8%
- Republic Power Group Ltd (RPGL:NASDAQ), 43%
- KalVista Pharmaceuticals, Inc. (KALV:NASDAQ), 38.62%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 37.22%